Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66


Comparison of Interferon-γ Release Assays and the Tuberculin Skin Test for Diagnosis of Tuberculosis in Human Immunodeficiency Virus: A Systematic Review.

Overton K, Varma R, Post JJ.

Tuberc Respir Dis (Seoul). 2018 Jan;81(1):59-72. doi: 10.4046/trd.2017.0072. Epub 2017 Dec 13.


HIV-1 Infection Is Associated with Depletion and Functional Impairment of Mycobacterium tuberculosis-Specific CD4 T Cells in Individuals with Latent Tuberculosis Infection.

Day CL, Abrahams DA, Harris LD, van Rooyen M, Stone L, de Kock M, Hanekom WA.

J Immunol. 2017 Sep 15;199(6):2069-2080. doi: 10.4049/jimmunol.1700558. Epub 2017 Jul 31.


Cutaneous tuberculosis: diagnosis, histopathology and treatment - part II.

Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, Silva PG, Medeiros VL.

An Bras Dermatol. 2014 Jul-Aug;89(4):545-55.


Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy.

Shim TS.

Tuberc Respir Dis (Seoul). 2014 Jun;76(6):261-8. doi: 10.4046/trd.2014.76.6.261. Epub 2014 Jun 28. Review.


Diagnostic performance of interferon-gamma releasing assay in HIV-infected patients in China.

Yu Y, Zhao X, Wang W, Wu H, Chen M, Hua W, Wang H, Wei T, Jiao Y, Sun G, Li W.

PLoS One. 2013 Aug 2;8(8):e70957. doi: 10.1371/journal.pone.0070957. Print 2013.


Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment.

Oni T, Gideon HP, Bangani N, Tsekela R, Seldon R, Wood K, Wilkinson KA, Goliath RT, Ottenhoff TH, Wilkinson RJ.

Clin Vaccine Immunol. 2012 Aug;19(8):1243-7. doi: 10.1128/CVI.00166-12. Epub 2012 Jun 20.


Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individuals.

Mitchell JE, Chetty S, Govender P, Pillay M, Jaggernath M, Kasmar A, Ndung'u T, Klenerman P, Walker BD, Kasprowicz VO.

PLoS One. 2012;7(6):e37920. doi: 10.1371/journal.pone.0037920. Epub 2012 Jun 7.


Incremental yield of serial sputum cultures for diagnosis of tuberculosis among HIV infected smear negative pulmonary TB suspects in Kampala, Uganda.

Ssengooba W, Kiwanuka N, Kateete DP, Katamba A, Joloba ML.

PLoS One. 2012;7(5):e37650. doi: 10.1371/journal.pone.0037650. Epub 2012 May 22.


Establishing the diagnosis of tuberculous vertebral osteomyelitis.

Colmenero JD, Ruiz-Mesa JD, Sanjuan-Jimenez R, Sobrino B, Morata P.

Eur Spine J. 2013 Jun;22 Suppl 4:579-86. doi: 10.1007/s00586-012-2348-2. Epub 2012 May 11. Review.


Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations.

Heemstra KA, Bossink AW, Spermon R, Bouwman JJ, van der Kieft R, Thijsen SF.

Clin Vaccine Immunol. 2012 Jun;19(6):974-7. doi: 10.1128/CVI.05597-11. Epub 2012 Mar 29.


A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.

Minassian AM, Satti I, Poulton ID, Meyer J, Hill AV, McShane H.

J Infect Dis. 2012 Apr 1;205(7):1035-42. doi: 10.1093/infdis/jis012.


Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study.

Pollock KM, Tam H, Grass L, Bowes S, Cooke GS, Pareek M, Montamat-Sicotte D, Kapembwa M, Taylor GP, Lalvani A.

BMJ Open. 2012 Mar 1;2(2):e000762. doi: 10.1136/bmjopen-2011-000762. Print 2012.


Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo.

Schuetz A, Haule A, Reither K, Ngwenyama N, Rachow A, Meyerhans A, Maboko L, Koup RA, Hoelscher M, Geldmacher C.

PLoS One. 2011;6(11):e27284. doi: 10.1371/journal.pone.0027284. Epub 2011 Nov 7.


Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.

Elzi L, Steffen I, Furrer H, Fehr J, Cavassini M, Hirschel B, Hoffmann M, Bernasconi E, Bassetti S, Battegay M.

BMC Infect Dis. 2011 Nov 15;11:319. doi: 10.1186/1471-2334-11-319.


Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.

Kasprowicz VO, Churchyard G, Lawn SD, Squire SB, Lalvani A.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1168-78. doi: 10.1093/infdis/jir449. Review.


Comparative utility of cytokine levels and quantitative RD-1-specific T cell responses for rapid immunodiagnosis of tuberculous meningitis.

Patel VB, Singh R, Connolly C, Kasprowicz V, Ndung'u T, Dheda K.

J Clin Microbiol. 2011 Nov;49(11):3971-6. doi: 10.1128/JCM.01128-11. Epub 2011 Aug 31.


A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.

Valentino MD, Abdul-Alim CS, Maben ZJ, Skrombolas D, Hensley LL, Kawula TH, Dziejman M, Lord EM, Frelinger JA, Frelinger JG.

J Immunol Methods. 2011 Oct 28;373(1-2):111-26. doi: 10.1016/j.jim.2011.08.007. Epub 2011 Aug 18.


Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.

Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence KA, Hensen B, Sismanidis C, Menezes A, Beyers N, Ayles H, Godfrey-Faussett P.

PLoS One. 2011 Apr 4;6(4):e18206. doi: 10.1371/journal.pone.0018206.

Supplemental Content

Support Center